Geographical accessibility to the supply of antiophidic sera in Brazil: Timely access possibilities
Antivenins
Science
Q
R
1. No poverty
Snake Bites
Transportation
Health Services Accessibility
3. Good health
03 medical and health sciences
Medicine
Humans
Registries
0305 other medical science
Brazil
Research Article
Demography
DOI:
10.1371/journal.pone.0260326
Publication Date:
2022-01-13T18:48:54Z
AUTHORS (3)
ABSTRACT
Snakebite accidents are considered category A neglected tropical diseases. Brazil stands out for snakebite accidents, mainly in the Amazon region. The best possible care after is to obtain antiophidic sera on time. And maximum ideal time reach it about 2 hours an accident. Based public health information and using a tool analyze geographical accessibility, we evaluate possibility of reaching Brazilian serum-providing facilities from relationship between population distribution commuting In this exploratory descriptive study, geographic accessibility that supply serum evaluated through methodology articulates several issues influence units (ACCESSMOD): facilities’ distribution, transportation network means, relief land use, which were obtained international sources. relative importance without facility two highlighted Macro-Regions, States municipalities. About nine million people live locations more than away facilities, with relevant variations regions, states, like Mato Grosso, Pará Maranhão had most important participation problems those units. significant gaps found areas dispersed sometimes characterized by high incidence snakebites, such as North country, especially Northeastern state. Even 2010 information, because 2020 Census postponement, tendencies characteristics analyzed reveal challenging situations over country. growing availability enhanced possibilities transporting accident victims, even other types establishments actions would allow expanding access supply.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (34)
CITATIONS (7)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....